首页 | 本学科首页   官方微博 | 高级检索  
     


Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases
Authors:G Smith  R A Elton  G D Chisholm  J E Newsam  T B Hargreave
Abstract:
Of 299 patients who presented with superficial bladder cancer (Ta, T1), 60 were treated by intravesical chemotherapy (Epodyl, methotrexate or mitomycin C). The rate of tumour progression to muscle invasion or metastases was identical for each intravesical regime. There was no evidence that mitomycin C promoted tumour progression. Carcinoma in situ in non-tumour-bearing urothelium was the most significant predictive factor for progression to muscle invasion or metastases.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号